Income Statement (TTM)
Ascletis Pharma Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82 | 35 | 37 | 40 | 58 | 77 | 78 | 79 | 66 | 54 | 58 | 62 | 59 | 57 | 33 | 10 | 6 | 1 | 2 | 2 |
| Change (%) | -57.54 | 6.74 | 6.31 | 46.78 | 31.87 | 1.09 | 1.07 | -15.57 | -18.44 | 7.66 | 7.12 | -4.63 | -4.86 | -41.09 | -69.74 | -43.64 | -77.44 | 42.13 | 29.64 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 60 | 74 | 85 | 95 | 67 | 38 | 25 | 12 | 46 | 79 | 76 | 73 | 52 | 31 | 27 | 23 | 12 | 1 | 1 | 2 |
| Change (%) | 22.28 | 14.65 | 12.78 | -30.25 | -43.36 | -33.50 | -50.37 | 266.52 | 72.72 | -3.79 | -3.93 | -28.98 | -40.81 | -12.88 | -14.79 | -48.79 | -95.29 | 87.59 | 46.69 | |
| % of Revenue | 73.23 | 210.89 | 226.52 | 240.30 | 114.19 | 49.04 | 32.27 | 15.84 | 68.78 | 145.65 | 130.16 | 116.74 | 86.93 | 54.08 | 79.97 | 225.17 | 204.59 | 42.71 | 56.38 | 63.79 |
| Gross Operating Profit | 22 | -39 | -47 | -56 | -8 | 39 | 53 | 66 | 21 | -25 | -18 | -10 | 8 | 26 | 7 | -13 | -6 | 1 | 1 | 1 |
| Change (%) | -275.84 | 21.78 | 17.89 | -85.15 | -573.45 | 34.37 | 25.58 | -68.68 | -219.26 | -28.86 | -40.57 | -174.49 | 234.26 | -74.30 | -289.07 | -52.91 | -112.36 | 8.23 | 7.61 | |
| % of Revenue | 26.77 | -110.89 | -126.52 | -140.30 | -14.19 | 50.96 | 67.73 | 84.16 | 31.22 | -45.65 | -30.16 | -16.74 | 13.07 | 45.92 | 20.03 | -125.17 | -104.59 | 57.29 | 43.62 | 36.21 |
| SG&A | 93 | 69 | 65 | 60 | 56 | 51 | 49 | 48 | 50 | 52 | 51 | 50 | 83 | 116 | 123 | 131 | 116 | 102 | 103 | 104 |
| Change (%) | -25.76 | -6.41 | -6.85 | -7.88 | -8.55 | -3.08 | -3.18 | 4.72 | 4.50 | -1.67 | -1.70 | 65.00 | 39.39 | 6.32 | 5.94 | -11.07 | -12.45 | 0.96 | 0.95 | |
| % of Revenue | 113.07 | 197.71 | 173.36 | 151.90 | 95.33 | 66.11 | 63.38 | 60.71 | 75.30 | 96.48 | 88.12 | 80.87 | 139.92 | 205.00 | 369.95 | 1,295.18 | 2,043.68 | 7,930.16 | 5,632.96 | 4,386.21 |
| R&D | 111 | 109 | 120 | 131 | 172 | 213 | 236 | 258 | 263 | 267 | 254 | 241 | 229 | 217 | 237 | 257 | 280 | 302 | 310 | 317 |
| Change (%) | -1.99 | 10.22 | 9.27 | 31.18 | 23.77 | 10.50 | 9.50 | 1.74 | 1.71 | -4.97 | -5.23 | -4.94 | -5.20 | 9.25 | 8.47 | 8.85 | 8.13 | 2.39 | 2.33 | |
| % of Revenue | 135.03 | 311.70 | 321.87 | 330.82 | 295.65 | 277.49 | 303.32 | 328.61 | 395.98 | 493.81 | 435.87 | 385.63 | 384.39 | 383.03 | 710.32 | 2,546.13 | 4,917.78 | 23,569.29 | 16,978.83 | 13,402.03 |
| OpEx | 311 | 284 | 294 | 304 | 306 | 307 | 315 | 323 | 363 | 403 | 385 | 367 | 366 | 366 | 389 | 412 | 409 | 406 | 415 | 423 |
| Change (%) | -8.77 | 3.58 | 3.46 | 0.51 | 0.50 | 2.51 | 2.45 | 12.38 | 11.02 | -4.44 | -4.65 | -0.19 | -0.19 | 6.37 | 5.99 | -0.76 | -0.76 | 2.16 | 2.11 | |
| % of Revenue | 377.50 | 811.18 | 787.22 | 766.10 | 524.57 | 399.79 | 405.44 | 410.96 | 546.99 | 744.51 | 660.82 | 588.25 | 615.66 | 645.88 | 1,166.19 | 4,084.65 | 7,192.97 | 31,638.04 | 22,740.22 | 17,911.17 |
| Operating Income | -229 | -249 | -257 | -265 | -248 | -230 | -237 | -244 | -296 | -349 | -327 | -305 | -307 | -309 | -355 | -402 | -403 | -405 | -413 | -421 |
| Change (%) | 8.81 | 3.14 | 3.04 | -6.44 | -6.88 | 2.99 | 2.90 | 21.37 | 17.60 | -6.32 | -6.75 | 0.72 | 0.72 | 15.07 | 13.09 | 0.32 | 0.32 | 2.03 | 1.99 | |
| % of Revenue | -277.50 | -711.18 | -687.22 | -666.10 | -424.57 | -299.79 | -305.44 | -310.96 | -446.99 | -644.51 | -560.82 | -488.25 | -515.66 | -545.88 | -1,066.19 | -3,984.65 | -7,092.97 | -31,538.04 | -22,640.22 | -17,811.17 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -15.62 | -14.07 | -16.38 | 14.43 | 12.61 | 6.00 | 5.66 | 6.07 | 5.72 | 4.14 | 3.98 | -7.65 | -8.28 | 14.58 | 12.73 | 15.59 | 13.49 | -5.12 | -5.40 | |
| % of Revenue | -0.19 | -0.39 | -0.31 | -0.24 | -0.19 | -0.16 | -0.17 | -0.18 | -0.22 | -0.29 | -0.28 | -0.27 | -0.26 | -0.25 | -0.49 | -1.84 | -3.78 | -19.02 | -12.70 | -9.26 |
| Net Income | -155 | -209 | -239 | -269 | -234 | -199 | -188 | -176 | -246 | -315 | -279 | -243 | -194 | -145 | -202 | -258 | -280 | -301 | -280 | -259 |
| Change (%) | 35.24 | 14.19 | 12.42 | -12.95 | -14.88 | -5.74 | -6.08 | 39.35 | 28.24 | -11.35 | -12.80 | -20.27 | -25.43 | 39.30 | 28.21 | 8.21 | 7.59 | -7.04 | -7.57 | |
| % of Revenue | -187.68 | -597.81 | -639.54 | -676.31 | -401.07 | -258.88 | -241.41 | -224.31 | -370.21 | -582.07 | -479.31 | -390.21 | -326.22 | -255.70 | -604.61 | -2,561.68 | -4,918.75 | -23,455.65 | -15,341.51 | -10,937.77 |
Source: Capital IQ
